Newsfeeds - Spark Newswire

3 minute read

FDA
News

Anika Launches WristMotion Total Wrist Arthroplasty System At American Society For Surgery Of The Hand Annual Meeting

Today, 10:55 AM

Anika Therapeutics, Inc. (NASDAQ:ANIK), a global joint preservation company, today announced its WristMotion® Total Wrist Arthroplasty (TWA) System was launched at the American Society for Surgery of

ANIK

1 minute read

Earnings

Return on Capital Employed Insights for Anika Therapeutics

By Benzinga Insights

Today, 10:55 AM

After pulling data from Benzinga Pro it seems like during Q2, Anika Therapeutics (NASDAQ:ANIK) earned $9.18 million, a 629.73% increase from the preceding quarter.

ANIK

1 minute read

Anika Therapeutics Q2 EPS $0.09 Beats $(0.06) Estimate, Sales $38.10M Beat $34.76M Estimate

By Benzinga Newsdesk

Today, 10:55 AM

Anika Therapeutics (NASDAQ:ANIK) reported quarterly earnings of $0.09 per share which beat the analyst consensus estimate of $(0.06) by 250 percent. This is unchanged from the same period last year. The company reported

ANIK

7 minute read

The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO

By Shanthi Rexaline

Today, 10:55 AM

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4)

ABSI

34 minute read

Earnings Scheduled For August 5, 2021

By Benzinga Insights

Today, 10:55 AM

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.

AAOI

6 minute read

The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs

By Shanthi Rexaline

Today, 10:55 AM

Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies.

ABUS

11 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For July 16, 2021

By Benzinga Insights

Today, 10:55 AM

1 minute read

UBS Initiates Coverage On Anika Therapeutics with Neutral Rating, Announces Price Target of $46

By Benzinga Newsdesk

Today, 10:55 AM

UBS initiates coverage on Anika Therapeutics (NASDAQ:ANIK) with a Neutral rating and announces Price Target of $46.

ANIK

3 minute read

News

Anika Therapeutics Highlights WristMotion Total Wrist Arthroplasty Surgery Performed

By Benzinga Newsdesk

Today, 10:55 AM

Anika Therapeutics, Inc. (NASDAQ:ANIK), a global joint preservation company in early intervention orthopedics, today announced the limited launch and first surgery performed with Anika's

ANIK

32 minute read

Uncategorized

Earnings Scheduled For May 6, 2021

By Benzinga Insights

Today, 10:55 AM

Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly earnings at $1.22 per share on revenue of $7.30 billion.

AAOI